CymaBay Therapeutics, Inc. (CBAY) has 20 known insider and institutional holders on record. The largest holder is Shah Sujal with 267,551 shares. Other notable holders include STUART LEWIS J and Van Wart Harold.
CBAY Insider Ownership
Top Holder
Shah Sujal
267,551 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Shah Sujal |
Chief Executive Officer |
267,551 |
2024-01-26 |
|
| 2 |
Stuart Lewis J |
Chief Commercial Officer |
215,000 |
2023-01-27 |
|
| 3 |
Van Wart Harold |
President and CEO |
200,000 |
2017-01-23 |
|
| 4 |
Boudes Pol F |
Chief Medical Officer |
138,312 |
2019-01-31 |
|
| 5 |
Martin Robert L. |
SVP, Nonclinical & Manuf. |
125,000 |
2018-01-26 |
|
| 6 |
Omara Patrick J. |
SVP, Business Development |
125,000 |
2018-01-26 |
|
| 7 |
Menold Daniel |
Vice President, Finance |
100,000 |
2023-01-27 |
|
| 8 |
Rosemark Kirk |
V.p. Regulatory & Quality |
50,000 |
2017-01-23 |
|
| 9 |
Von Emster Kurt |
Director |
49,245 |
2020-05-19 |
|
| 10 |
Mcwherter Charles |
President of R&d |
46,938 |
2024-01-26 |
|
| 11 |
Truex Paul F |
Director |
32,000 |
2021-01-28 |
|
| 12 |
Booth Robert F. |
Director |
27,705 |
2019-01-31 |
|
| 13 |
Goldfischer Carl |
Director |
27,705 |
2019-01-31 |
|
| 14 |
Weiland Robert J. |
Director |
27,705 |
2019-01-31 |
|
| 15 |
Stein Evan A. |
Director |
27,705 |
2019-01-31 |
|
| 16 |
Alta Biopharma Partners Iii Lp |
10 Percent Owner |
23,668 |
2013-10-11 |
|
| 17 |
Dickinson Klara |
Chief Regulatory Officer |
21,000 |
2024-01-26 |
|
| 18 |
Shantharam Harish |
Chief Financial Officer |
20,125 |
2024-01-26 |
|
| 19 |
Kim Dennis D |
Chief Medical Officer |
20,000 |
2023-04-17 |
|
| 20 |
Dorling Janet |
Director |
14,010 |
2024-01-26 |
|
No ownership data available for CBAY.
